Immunic Inc (NASDAQ:IMUX)
| 1.47 Delayed Data As of Sep 20 |  +0.075 / +5.38%Today’s Change | 1.11 Today|||52-Week Range 11.76 | +5.00% Year-to-Date |
Latest IMUX News | Press Releases
No recent news for Immunic Inc.
Today’s Trading
| Previous close | 1.40 |
| Today’s open | 1.40 |
| Day’s range | 1.39 - 1.52 |
| Volume | 433,667 |
| Average volume (3 months) | 841,290 |
| Market cap | $66.9M |
Data as of 3:59pm ET, 09/20/2023
Growth & Valuation
| Earnings growth (last year) | +3.70% |
| Earnings growth (this year) | +44.18% |
| Earnings growth (next 5 years) | +15.51% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SLGLSol Gel Technologies... | -0.11 | -4.95% |
| CRDLCardiol Therapeutics... | -0.00 | -0.01% |
| ---- | ||
| ---- |
Data as of 3:58pm ET, 09/20/2023
Financials
| Next reporting date | November 9, 2023 |
| EPS forecast (this quarter) | -$0.51 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$120.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
